Clinical study - Appareil pulmonaire
FDG-Immun
Appareil pulmonaire
Ouvert depuis le: 07.27.2024
Site: Paris
Public cible
Adulte
Cohort Study Evaluating 18FDG PET for Early Identification of Tumor Exhaust for Immunotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Bronchopulmonary Carcinoma or Melanoma
Description de l'essai
The hypothesis of this diagnostic performance study is that, for patients treated for immunotherapy-treated melanoma or NSCLC, some metabolic parameters of the 18FDG dual-point PET scan distinguish inflammatory pseudo-progression from tumor progression true and thus improve the evaluation of tumor response to immunotherapy.
Liens utiles
MARIE LUPORSI
Investigateur principal